Leukemia & Lymphoma, Volume 63, Issue 4 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 63, Issue 4 (2022)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Volume 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Ferritin, sex, and the wildfire of inflammation in Hodgkin lymphoma
Adam J. Olszewski
Pages: 765-767
Published online: 02 Feb 2022
First Page PreviewforFerritin, sex, and the wildfire of inflammation in Hodgkin lymphoma | Full Text | References | PDF (408.6 KB) | EPUB
  • 126 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma
Jan-Michel Heger & Sven Borchmann
Pages: 768-770
Published online: 12 Jan 2022
First Page PreviewforComing of age: the evolving role of circulating tumor DNA in malignant lymphoma | Full Text | References | PDF (404.5 KB) | EPUB
  • 117 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Be on guard: longer monitoring for very–late onset hepatitis B virus reactivation after chemo-immunotherapy?
Chava Perry
Pages: 771-773
Published online: 10 Feb 2022
First Page PreviewforBe on guard: longer monitoring for very–late onset hepatitis B virus reactivation after chemo-immunotherapy? | Full Text | References | PDF (303.5 KB) | EPUB
  • 79 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
Novel strategies for challenging scenarios encountered in managing myelofibrosis
Prithviraj Bose & Ruben A. Mesa
Pages: 774-788
Published online: 15 Nov 2021
AbstractforNovel strategies for challenging scenarios encountered in managing myelofibrosis | Full Text | References | PDF (3 MB) | EPUB | Supplemental
  • 549 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma
Madhav R. Seshadri & Ari M. Melnick
Pages: 789-798
Published online: 16 Nov 2021
AbstractforTargeting MALT1 for the treatment of diffuse large B-cell lymphoma | Full Text | References | PDF (1,023.3 KB) | EPUB
  • 873 Views
  • 10 CrossRef citations
  • 0Altmetric

Original Articles

Article
Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance
Stamatios Karakatsanis, Fotios Panitsas, Maria Arapaki, Dimitrios Galopoulos, John V. Asimakopoulos, Athanassios Liaskas, Chrysovalantou Chatzidimitriou, Marina Belia, Elianna Konstantinou, Ioannis Vassilopoulos, Stamatis S. Papadatos, Sotirios Sachanas, Maria Efstathopoulou, Xanthoula Yiakoumis, Vassilios Pardalis, Theodoros Iliakis, Nefeli Giannakopoulou, Maria Dimou, Sevastianos Chatzidavid, George Boutsikas, Kyriaki Petevi, Alexandros Kanellopoulos, Gabriella Gainaru, Eleni Variamis, Marina P. Siakantaris, Marie-Christine Kyrtsonis, Eleni Plata, Panayiotis Tsaftaridis, Maria N. Dimopoulou, Nora-Athina Viniou, Konstantinos N. Syrigos, Gerassimos A. Pangalis, Panayiotis Panayiotidis, Kostas Konstantopoulos, Maria K. Angelopoulou & Theodoros P. Vassilakopoulos
Pages: 799-812
Published online: 19 Feb 2022
AbstractforSerum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance | Full Text | References | PDF (1.9 MB) | EPUB
  • 193 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents
Harsh Shah, Hyejeong Jang, Paramveer Singh, Jorgena Kosti, Andrew Kin, Asif Alavi, Voravit Ratanatharathorn, Lois Ayash, Joseph Uberti, Radhakrishnan Ramchandren, Seongho Kim & Abhinav Deol
Pages: 813-820
Published online: 15 Nov 2021
AbstractforImproved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 211 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
Ahmad S. Halwani, Carlos Panizo, Iris Isufi, Alex F. Herrera, Craig Y. Okada, Elizabeth H. Cull, Bela Kis, Jorge M. Chaves, Nancy L. Bartlett, Weiyun Ai, Luis de la Cruz-Merino, Locke J. Bryan, Roch Houot, Kim Linton, Javier Briones, Ian Chau, Gottfried R. von Keudell, Hailing Lu, Adam Yakovich, Michael Chen, ter Meulen JH, Sergey Yurasov, Frank J. Hsu & Christopher R. Flowers
Pages: 821-833
Published online: 06 Dec 2021
AbstractforPhase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma | Full Text | References | PDF (1.9 MB) | EPUB
  • 436 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study
Vincent Camus, Mathieu Viennot, Emilie Lévêque, Pierre-Julien Viailly, David Tonnelet, Elena-Liana Veresezan, Fanny Drieux, Pascaline Etancelin, Sydney Dubois, Aspasia Stamatoullas, Hervé Tilly, Elodie Bohers & Fabrice Jardin
Pages: 834-844
Published online: 25 Jan 2022
AbstractforCirculating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study | Full Text | References | PDF (1 MB) | EPUB
  • 356 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison
Stephen J. Schuster, Jie Zhang, Hongbo Yang, Abhijit Agarwal, Wenxi Tang, Marcela Martinez-Prieto, Vamsi Bollu, David Kuzan, Richard T. Maziarz & Marie José Kersten
Pages: 845-854
Published online: 02 Jan 2022
AbstractforComparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison | Full Text | References | PDF (1.1 MB) | EPUB
  • 3246 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Allogeneic hematopoietic stem cell transplantation in T-cell lymphoma: a Meta-Analysis
Vijendra Singh, Seongho Kim, Abhinav Deol, Joseph P. Uberti & Dipenkumar Modi
Pages: 855-864
Published online: 05 Dec 2021
AbstractforAllogeneic hematopoietic stem cell transplantation in T-cell lymphoma: a Meta-Analysis | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 448 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia
Rashmi Kanagal-Shamanna, Haiyan Bao, Hutton Kearney, Stephanie Smoley, Zhenya Tang, Rajyalakshmi Luthra, Hui Yang, Shanshan Zhang, Pei Lin, Depei Wu, L. Jeffrey Medeiros & Xinyan Lu
Pages: 865-875
Published online: 13 Dec 2021
AbstractforMolecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia | Full Text | References | PDF (2.5 MB) | EPUB
  • 282 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience
Terry K. Pak, Brianne N. Dixon, Michael J. Buege, Phuong H. Dao, Megan H. Leary, Joy C. Jarrett, Tara A. Duggan, Philip Caron, Lorenzo Falchi, Paul Hamlin, Audrey Hamilton, Matthew J. Matasar, Alison Moskowitz, Ariela Noy, Colette N. Owens, Gottfried Von Keudell, Anas Younes, Andrew D. Zelenetz & Anita Kumar
Pages: 876-884
Published online: 16 Nov 2021
AbstractforSuccessful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience | Full Text | References | PDF (882.2 KB) | EPUB
  • 338 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors
Akash Mukherjee, Denái R. Milton, Elias J. Jabbour, Alison M. Gulbis, Tapan Kadia, Nitin Jain, Celina Ledesma, Jan Burger, Alessandra Ferrajoli, William Wierda, L. Jeffrey Medeiros, Hagop Kantarjian, Richard Champlin & Issa F. Khouri
Pages: 885-893
Published online: 27 Feb 2022
AbstractforClinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors | Full Text | References | PDF (744.4 KB) | EPUB
  • 244 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Comparative analysis of international prognostic indices in gray-zone lymphoma
Hanno M. Witte, Hartmut Merz, Heinz-Wolfram Bernd, Arthur Bauer, Veronica Bernard, Alfred C. Feller & Niklas Gebauer
Pages: 894-902
Published online: 02 Dec 2021
AbstractforComparative analysis of international prognostic indices in gray-zone lymphoma | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 139 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Patricia Pérez-Galán, Laura Magnano & Armando López-Guillermo
Pages: 903-910
Published online: 29 Nov 2021
AbstractforThe Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma | Full Text | References | PDF (2 MB) | EPUB
  • 187 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage
Arshia Soleimani, Alba Navarro, Delong Liu, Sarah E. M. Herman, Shih-Sung Chuang, Irma Slavutsky, Marina Narbaitz, Hana Safah, John Schmieg, John Lefante, Mark Roschewski, Wyndham H. Wilson, Adrian Wiestner & Nakhle S. Saba
Pages: 911-917
Published online: 15 Nov 2021
AbstractforCD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 409 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches
Amanda C. Przespolewski, Scott Portwood & Eunice S. Wang
Pages: 918-927
Published online: 25 Nov 2021
AbstractforTargeting acute myeloid leukemia through multimodal immunotherapeutic approaches | Full Text | References | PDF (2.8 MB) | EPUB | Supplemental
  • 307 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*
Toshihiro Miyamoto, David Sanford, Ciprian Tomuleasa, Hui-Hua Hsiao, Leonardo José Enciso Olivera, Anoop Kumar Enjeti, Alberto Gimenez Conca, Teresa Bernal del Castillo, Larisa Girshova, Maria Paola Martelli, Birol Guvenc, Alexander Delgado, Yinghui Duan, Belen Garbayo Guijarro, Cynthia Llamas & Je-Hwan Lee
Pages: 928-938
Published online: 11 Feb 2022
AbstractforReal-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy* | Full Text | References | PDF (1.4 MB) | EPUB
  • 3451 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Determinants of ten-year overall survival of acute myeloid leukemia: a large national cancer database analysis
Nabin Khanal, Valerie Shostrom, Prajwal Dhakal, Shristi Upadhyay Banskota, Chakra Chaulagain, Fiona He, Kailash Mosalpuria, Krishna Gundabolu & Vijaya Raj Bhatt
Pages: 939-945
Published online: 17 Nov 2021
AbstractforDeterminants of ten-year overall survival of acute myeloid leukemia: a large national cancer database analysis | Full Text | References | PDF (876.6 KB) | EPUB | Supplemental
  • 264 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States
Xiaomeng Yue, Ana L. Hincapie, Yuxiang Li & Jeff J. Guo
Pages: 946-954
Published online: 15 Nov 2021
AbstractforSafety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States | Full Text | References | PDF (1 MB) | EPUB
  • 363 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment
Damla Buket Egeli, Benjamin Hanfstein, Michael Lauseker, Markus Pfirrmann, Susanne Saussele, Gabriela M. Baerlocher & Martin C. Müller
Pages: 955-962
Published online: 06 Dec 2021
AbstractforSOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment | Full Text | References | PDF (841.2 KB) | EPUB
  • 94 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Aberrant ENPP2 expression promotes tumor progression in multiple myeloma
Yuxiang Li, Lin Zhang, Tianxin Xu, Xia Zhao, Xiaona Jiang, Fengjun Xiao, Huiyan Sun & Lisheng Wang
Pages: 963-974
Published online: 30 Nov 2021
AbstractforAberrant ENPP2 expression promotes tumor progression in multiple myeloma | Full Text | References | PDF (2.3 MB) | EPUB
  • 195 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma
David Yashar, Tanya M. Spektor, Daisy Martinez, Matthew Ghermezi, Regina A. Swift, Benjamin Eades, Gary Schwartz, Shahrooz Eshaghian, Stephen Lim, Robert Vescio & James R. Berenson
Pages: 975-983
Published online: 24 Nov 2021
AbstractforA phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma | Full Text | References | PDF (836.3 KB) | EPUB | Supplemental
  • 444 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes
Laurent Garderet, Mohammad Al Hariri, Joanna Wasielica-Poslednik, Markus Munder, Kitti Kormányos, Camila Pena, Alessandro Gozzetti, Xiang Zhou, Anna Waszczuk-Gajda, Laura Rosinol, Gabor Mikala, Mateusz Krzystanski, Walter Lisch, David Vesole, Nóra Szentmáry & Artur Jurczyszyn
Pages: 984-990
Published online: 25 Nov 2021
AbstractforMonoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes | Full Text | References | PDF (1.1 MB) | EPUB
  • 287 Views
  • 2 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Very late-onset hepatitis B reactivation following chemoimmunotherapy
Edward R. Scheffer Cliff, Joe Sasadeusz, Kumar Visvanathan & Andrew Grigg
Pages: 991-995
Published online: 02 Dec 2021
First Page PreviewforVery late-onset hepatitis B reactivation following chemoimmunotherapy | Full Text | References | PDF (621.6 KB) | EPUB
  • 378 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia
Raffaele Palmieri, Francesco Buccisano, Valentina Arena, Maria Antonietta Irno Consalvo, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria DelPrincipe, Ambra Di Veroli, Giovangiacinto Paterno, Consuelo Conti, Daniela Fraboni, Maria Teresa Voso, William Arcese & Adriano Venditti
Pages: 996-1000
Published online: 21 Nov 2021
First Page PreviewforCD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia | Full Text | References | PDF (992.9 KB) | EPUB | Supplemental
  • 179 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy
Hui Liu, Ping Li, Aiqi Zhao, Wen Lei, Aibin Liang & Wenbin Qian
Pages: 1001-1004
Published online: 28 Nov 2021
First Page PreviewforIncidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy | Full Text | References | PDF (980.4 KB) | EPUB | Supplemental
  • 320 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Mitochondrial biogenesis gene POLG correlates with outcome in pediatric acute myeloid leukemia
Shilpi Chaudhary, Shuvadeep Ganguly, Archna Singh, Jayanth Kumar Palanichamy, Radhika Bakhshi, Anita Chopra & Sameer Bakhshi
Pages: 1005-1008
Published online: 25 Jan 2022
First Page PreviewforMitochondrial biogenesis gene POLG correlates with outcome in pediatric acute myeloid leukemia | Full Text | References | PDF (638.7 KB) | EPUB
  • 136 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Prolonged Epstein-Barr virus reactivation coincident with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Hiroki Hosoi, Yoriko Matsuyama, Shogo Murata, Toshiki Mushino & Takashi Sonoki
Pages: 1009-1012
Published online: 16 Nov 2021
First Page PreviewforProlonged Epstein-Barr virus reactivation coincident with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (529.7 KB) | EPUB
  • 122 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement
Yukiko Doi, Takafumi Yokota, Hirohiko Shibayama, Kana Matsumoto, Masako Kurashige, Kenji Nozaki, Jiro Fujita, Kentaro Fukushima & Naoki Hosen
Pages: 1013-1015
Published online: 02 Dec 2021
First Page PreviewforA forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement | Full Text | References | PDF (892.9 KB) | EPUB | Supplemental
  • 98 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles